1 5 IE GU LAT I 0 NI F 4ek lsi D E Psi E In prokaryotic cells, gene regulation usually occurs at the level of transcription. Examples are operons—the trp operon and the lac operon. The trp operon is a repressible operon because the repressor coded by a regulator gene must bind with a corepressor (i.e., tryptophan) before the complex can bind to the operator and stop protein synthesis.In the lac operon, a repressor protein ordinarily binds the operator so that RNA polymerase is unable to bind to the promoter and transcription is therefore unable to take place. When lactose is present, it binds to the repressor, and then this combination is unable to bind to the operator. The lac operon is an inducible operon. Eukaryotic cells have five levels of control (gene regulation): chromatin structure, transcriptional, posttranscriptional, translational, and posttranslational. Chromatin packing is used as a way to keep genes turned off. Transcriptional control includes the use of transcription ElsiE Acrivui—Yr 1"1 Li -1-"-rr- I co Isi s activators and factors. Posttranscriptional control includes mRNA processing and the speed with which mRNA leaves the nucleus. Translational control pertains to the life expectancy of mRNA molecules, which can vary; some mRNAs may need modification before they can be translated. Some of these modifications may be signals from microRNA. Posttranslational control includes activation of the protein product and degradation of a protein. Mutations are changes in DNA nucleotide base sequences. Types of mutations include point and frameshift mutations. Mutations can be spontaneous or caused by an environmental mutagen. Carcinogens are mutagens that cause cancer. Cancer is due to a series of genetic mutations among regulatory genes that control the cell cycle. These mutations activate oncogenes or deactivate tumor suppressor genes, resulting in uncontrolled cell division that leads to a tumor. Study the text section by section as you answer the questions that follow. • Regulator genes control the expression of genes that code for a protein product. 1. a. Label the following diagram of an operon, using the alphabetized list of terms. active repressor mRNA operator promoter regulator gene structural genes transcription is prevented 126 h. Which of these codes for a repressor? i. To which of these does RNA polymerase bind? j. To which of these does the repressor bind? k. Which of these codes for enzymes of the pathway? 2. Cross out all portions of the following diagram that are not in use if the trp operon is turned regulator gene operator inactive } on. structural genes enzymes repressor tryptophan 3. Cross out all portions of the following diagram that are not in use if the lac operon is turned off. regulator gene (----"----operator 4 structural genes ,. active } repressor + inducer 1 enzymes 4. Put this sequence of events in order to describe how E. coli ensures that the lac operon is maximally turned on when glucose is absent. a. Cyclic AMP builds up. b. Now RNA polymerase is better able to bind to the promoter. c. Cyclic AMP binds to catabolite activator protein (CAP). d. The complex attaches to a CAP binding site next to the lac promoter. 5. a. With the trp operon, are the structural genes ordinarily turned on or off? b. Why is the trp operon a repressible operon? icixiwyca-r ■ Fc LA1IF4 P • The control of gene expression can occur at all stages, from transcription to the activity of proteins in the eukaryotic cell. • Transcriptional control is more significant than posttranscriptional control. 6. Complete the following table: Level of Control of Gene Activity 1. 2. 3. 4. 5. Affects the Activity Of 7. Indicate whether these statements about euchromatin and heterochromatin are true (T) or false (F). Decompacted euchromatin is inactive. a. Looped euchromatin is actively being transcribed. b. c. Highly compacted and condensed heterochromatin is inactive. Heterochromatin is actively being transcribed. d. 8. a. Which statement in question 7 is supported by knowledge of Barr bodies? b. Why? 9. a. Which statement in question 7 is supported by knowledge of lampbrush chromosomes? 11_ Why? 10. Consider the following diagram: T7anscription activators bind to enhancer. promoter eleNN 1 - DNA I gene 0" 1 enhancer / ,,,,. "(X, .."qr . ■ ....., e - - ' ' N"k 0.. - mediator . proteins 63 rN '''' ‘. \ "CN, ""C.• jilt Transcription factors lile41:44000 Transcription factors bind to promoter. I --,*,,-.‘ , -•(, Nik.,74‘ he -4,,..• %, 04 **I %„ .t.„ N RNA polymerase f - ° „ I ^ ' ‘N. 4:•• ihA RNA polymerase binds. — „," -4c,N,, - mff RNA t polymerase lo.ifi .10 '''.- ' ' ' ■,.) 0" mik.411/43 --... mRNA transcription begins. a. What are transcription factors? b. Where do transcription factors bind? c. Where do transcription activators bind? d. What conformational change occurs before transcription begins? 11 Question 10 pertains to what level of genetic control in eukaryotes? 12 A DNA sequence that can move between chromosomes is called a 13. Place the appropriate letters next to each statement. PTC—posttranscriptional control a. b. c. d. TL—translational control PTL—posttranslational control The product of a metabolic pathway binds to an enzyme that speeds the first reaction of the pathway. mRNA persists for different lengths of time in cells. Introns are processed into smaller signals called microRNAs. Patterns of mRNA splicing differ. • Mutations occur when the nucleotide base sequence of DNA changes. • Mutations can lead to proteins that do not function or do not function properly. • Mutations of regulatory genes are now known to cause cancer. 14. The original base sequence is UACUACUAC. a. Name the mutation that reads UAUACUACU. b. Name the mutation that reads UACUAGUAC. c. Which of these two types of mutations causes sickle cell disease? 15. The mutation of a a. b. . to an oncogene and/or a tumor suppressor gene can lead to a When a tumor is at its place of origin, it is said to be C. cancer usually leads from a localized tumor to a d ' e. . The development of tumor, found at some distance from the tumor. The p53 gene is a f. gene. The p53 protein acts as a g. expression of genes whose products are h ' inhibitors. i. factor and can turn on , programmed cell death, can also be stimulated by the p53 gene. 16. Place the appropriate letters next to each description. Two answers are required for each statement. P—proto-oncogenes 0—oncogenes T—tumor suppressor genes MT—mutated tumor suppressor gene a. b. c. cell division is always promoted normal genes in cells that regulate cell division mutated genes that cause cancer 17 a. Aside from replication errors, what affects the rate of mutation? b. How is DNA protected against mutations due to environmental mutagens? 18. a. What is a carcinogenic mutagen? b. Name two environmental factors that are carcinogenic. 129 KEYWC:›RC0 CROSSWCORC1 Review key terms by completing this crossword puzzle, using the following alphabetized list of terms: Barr body carcinogen corepressor frameshift genetic hi stone inducer operator point promoter repressor transposon Across 1 Molecule that binds to a repressor, allowing the repressor to bind to an operator in a repressible operon 3 In an operon, a sequence of DNA where RNA polymerase binds prior to transcription 5 Mutation of a gene in which the insertion or deletion of at least one base changes the corresponding mRNA 7 Altered gene mutation whose sequence of bases differs from the previous sequence 8 DNA sequence capable of randomly moving from one site to another in the genome 9 Mutation of a gene in which there is a change of one base only in the sequence of bases 10 Protein molecule responsible for packing chromatin 11 Molecule that brings about activity of an operon by joining with a repressor and preventing it from binding to the operator Down 1 Environmental agent that causes mutations, leading to the development of cancer 2 In an operon, the sequence of DNA to which the repressor protein binds 4 Dark-staining body in the nuclei of female mammals that contains a condensed, inactive X chromosome (two words) 6 In an operon, a protein molecule that binds to an operator, preventing RNA polymerase from binding to the promoter site
© Copyright 2024